Preprint · OA
via OpenAlex
α-Synuclein: A therapeutic target for Parkinson’s disease?
Pharmacological Research · 2008 · ▲ 42 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.phrs.2008.09.006
- Canonical
- link ↗
- Fetched
- 2026-10-21 MST
Cite this
APA
Maguire‐Zeiss, K.A. (2008). α-Synuclein: A therapeutic target for Parkinson’s disease?. <em>Pharmacological Research</em>. https://doi.org/10.1016/j.phrs.2008.09.006
Vancouver
Maguire‐Zeiss KA. α-Synuclein: A therapeutic target for Parkinson’s disease?. Pharmacological Research. 2008. doi:10.1016/j.phrs.2008.09.006.
BibTeX
@unpublished{kathleen2008Synucl,
title = {α-Synuclein: A therapeutic target for Parkinson’s disease?},
author = {Kathleen A. Maguire‐Zeiss},
journal = {Pharmacological Research},
year = {2008},
doi = {10.1016/j.phrs.2008.09.006},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Neurology 2022
Open access · OA
Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson’s disease
Handbook of clinical neurology 2022
Preprint · OA
T cells, α-synuclein and Parkinson disease
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2011
Open access · OA
α-Synuclein misfolding and Parkinson's disease
The Lancet 2009
Citation only
Parkinson's disease
The Lancet 2021
Open access · OA
Parkinson's disease
Acta Neuropathologica 2007
Citation only